MENU
+Compare
LAB
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$1.30
Change
+$0.01 (+0.78%)
Capitalization
496.59M

LAB Standard BioTools Forecast, Technical & Fundamental Analysis

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more

LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LAB with price predictions
Sep 05, 2025

Momentum Indicator for LAB turns positive, indicating new upward trend

LAB saw its Momentum Indicator move above the 0 level on September 03, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where LAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LAB just turned positive on September 03, 2025. Looking at past instances where LAB's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

LAB moved above its 50-day moving average on September 05, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LAB advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for LAB crossed bearishly below the 50-day moving average on August 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LAB entered a downward trend on August 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.170) is normal, around the industry mean (60.043). P/E Ratio (0.000) is within average values for comparable stocks, (38.046). LAB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.677). LAB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (2.840) is also within normal values, averaging (80.366).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LAB is expected to report earnings to -4 cents per share on November 11

Standard BioTools LAB Stock Earnings Reports
Q3'25
Est.
$-0.05
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 1.41M shares outstanding, the current market capitalization sits at 496.59M.
A.I. Advisor
published General Information

General Information

a manufacturer of integrated fluidic circuit systems

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2 Tower Place
Phone
+1 650 266-6000
Employees
539
Web
https://www.standardbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASCQX17.840.03
+0.17%
American Century Small Company I
SROCX13.39N/A
N/A
Calamos Antetokounmpo Sustainable Eqs C
CSECX34.28-0.07
-0.20%
Calvert Equity C
MGOCX34.19-0.09
-0.26%
NYLI WMC Enduring Capital Class C
FGIPX16.71-0.07
-0.42%
Macquarie Growth and Income Instl

LAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LAB has been loosely correlated with TMCI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
+0.78%
TMCI - LAB
44%
Loosely correlated
N/A
CERS - LAB
44%
Loosely correlated
N/A
ENOV - LAB
44%
Loosely correlated
+1.84%
CLPT - LAB
43%
Loosely correlated
-0.27%
BLFS - LAB
42%
Loosely correlated
+2.28%
More

Groups containing LAB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
+0.78%
Medical/Nursing Services
industry (226 stocks)
43%
Loosely correlated
+0.46%
Health Services
industry (439 stocks)
33%
Loosely correlated
-0.02%